Heart disease is the leading cause of death for both men and women in the United States.
Lipid profiles have been a cornerstone of heart disease prevention. While it is common to use LDL “bad” and HDL “good” cholesterol measurements to determine a patient’s risk for heart disease, this approach only shows the “tip of the iceberg”. A comprehensive approach to risk stratification should include newer markers to personalize a patient’s risk assessment and create an opportunity for an actionable plan. Learn how advanced testing can help in identifying risk and assist with management plans.
Join us on February 21 as Dr. Regina Druz, MD provides and overview of advanced cardiovascular testing options
